TrialCancer immunology, immunotherapy : CII2025

Association of lymphocyte subsets percentage with prognosis for recurrent or metastatic nasopharyngeal carcinoma patients receiving PD-L1 inhibitors.

Jianming Diao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.